Xero-Gel Drug-Coated PTCA Balloon

Optimizing Drug Delivery

Our proprietary Xero-Gel drug-coated PTCA balloon includes a bio-active medical coating designed to improve adhesion of organic and inorganic substrates and optimize drug delivery.

Developed at a leading, international medical university, the novel coating enables a unique and efficient excipient to carry a non-proliferative drug on the surface of PTCA balloons and has the flexibility to be modified to accommodate a number of clinical applications.

Applications:

  • Small Vessel Stenosis, restenosis and bifurcations

  • PTCA Balloons

  • Vascular Stents

Material Compatibility:

  • Metal/metal oxide (SS, Cobalt-Chromium, Nitinol, Titanium, Magnesium)

  • Polymers

Licensing Opportunities

The Xero-Gel drug-coated PTCA balloon is currently being evaluated in animal studies to evaluate effectiveness in treating  coronary artery disease and address unmet clinical needs such as small vessel stenosis, restenosis, and bifurcations.  

Alta Biomed is currently looking for interested parties seeking licensing opportunities of this novel technology.

Contact us today to learn more.